Updated for 2023
Summit Participation Policy

Since 2017, the Genetic Health Information Network Summit has convened influential leaders from across healthcare, genomics, and technology for a uniquely engaging, solution-oriented meeting on enabling cost-effective precision medicine at scale.

There is no other meeting like the Summit. Feedback from leaders who participate is consistent, from health plan CMOs and federal policymakers to clinical genetics experts and researchers to investors and entrepreneurs: The Summit brings together the necessary stakeholders to make meaningful change in the U.S. healthcare system.

Due to its unique format, the meeting has limited space and hits capacity each year. As demand for the meeting has continued to rise, the attendance policy has been updated for 2023.

Participation Policy:

  • Participation at the Summit is by invitation only, and invitations are non-transferrable. Invitations will be issued on a rolling basis starting in mid June.
  • Organizations are generally limited to 1 representative. Organizers and speakers do not count against this limit. Exceptions are made on a case-by-case basis by Summit organizers. Additional participants beyond the 1st will need to register at the General Admission rate.

If you have any questions, please contact Nick Tazik at ntazik[at]concertgenetics.com.

Past Organizers, Speakers & Participants

Titles and organizational affiliations may be reflective of the time of the event and may have since changed.

FRANCIS COLLINS, MD, PhD
Acting Science Advisor to the President of the United States
White House

CARLOS BUSTAMANTE, PhD
Founder & CEO
Galatea Bio

TRISH BROWN, MS, CGC
Genomics and Precision Medicine Program Director
Aetna

GILLIAN HOOKER, PhD, ScM, CGC
Chief Scientific Officer
Concert Genetics

SUZANNE BELINSON, PhD, MPH
VP, Commercial Markets
Tempus

PRISCILLA ALFARO, MD
VP, Payment Integrity
BCBS North Carolina

STEVE GOLDBERG, MD
VP, Chief Health Officer, Medical Affairs & Diagnostic Services
Quest Diagnostics

VINCENT NELSON, MD
SVP & Deputy CMO
Centene

ROBERT NUSSBAUM, MD
Chief Medical Officer
Invitae

ANDY CORTS
SVP, Research & Analytics
SignalPath, a Verily company

BEN HO PARK, MD, PHD
Professor & Director, Division of Hematology and Oncology
Vanderbilt University Medical Center

ESTEBAN LÓPEZ
Chief Medical Officer, Clinical Strategy Innovation
HCSC (BCBS of IL, MT, NM, OK & TX)

SIMON BARNETT
Genomics Analyst
ARK Invest

DEE ANNA SMITH
CEO
Sarah Cannon

GEORGE CARDOZA
Senior Vice President, Chief Financial Officer
NeoGenomics

SEAN HOFHERR, PhD
Chief Scientific Officer
GeneDx, Inc.

JULIE M EGGINGTON, MS, PhD
Co-founder & CEO
Center for Genomic Interpretation

ERYNN GORDON, MS, LCGC
VP, Clinical Operations
Genome Medical

NIKOLETTA SIDIROPOULOS, MD
Medical Director, Genomic Medicine, Department of Pathology and Laboratory Medicine
University of Vermont Health Network

PHILLIP FEBBO, MD
SVP & Chief Medical Officer
Illumina

HOWARD LEVY, MD, PhD
Associate Professor of Medicine
Johns Hopkins Medicine

KATE DONIGAN, PHD
Deputy Director, Personalized Medicine & Molecular Genetics (acting)
FDA

JILL HAGENKORD, MD
Chief Medical Officer
Optum Genomics

JIM JIRJIS, MD
Chief Health Information Officer
HCA Healthcare

BENJAMIN SOLOMON, MD
Clinical Director, National Human Genome Research Institute (NHGRI)
NIH

HOLLI DILKS, MD
Senior Director, Global Head of Field Medical
Foundation Medicine

ROBERT C. GREEN, MD, MPH
Director, Genomes2People
Division of Genetics at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School

JEFF EMCH
VP, Diagnostics Strategy, Global Oncology Marketing
GSK

NICOLE BOICE
Founder & CEO
Global Genes

DAVID MCCALLIE, MD
SVP, Medical Informatics
Cerner

EDWARD ABRAHAMS, PhD
President
Personalized Medicine Coalition

TAHA KASS-HOUT, MD
Former 1st Chief Health Informatics Officer
U.S. Food and Drug Administration (FDA)

GIL ALTEROVITZ, PhD
Director, Biomedical Cybernetics Laboratory
Harvard Medical School

KRISTINE BORDENAVE, MD
Corporate Medical Director
Humana

JOSHUA DENNY, MD
Professor of Biomedical Informatics and Medicine
Vanderbilt University

JAMES O’LEARY
Chief Innovation Officer
Genetic Alliance

HENRY GARLICH
Director, Healthcare Value Solutions & Enhanced Clinical Programs
Blue Shield of California

JIM ALMAS, MD
VP & National Medical Director for Clinical Effectiveness
LabCorp

MARA ASPINALL
Managing Director and Co-Founder
BlueStone Venture Partners

TRENT HAYWOOD, MD, JD
SVP & Chief Medical Officer
Blue Cross Blue Shield Association

PETER DEVAULT
VP, Genomics & Interoperability
Epic

STEPHANIE DEVANEY, PHD
Deputy Director, All of Us
NIH

EDMUND JACKSON, PHD
Chief Data Officer
HCA Healthcare

LISA ALDERSON
Co-founder & CEO
Genome Medical

DEBRA ESSER, MD
Chief Medical Officer
Blue Cross and Blue Shield of Nebraska

LAURIE MCGRAW
SVP, Health Solutions
American Medical Association

KATHRYN LANG, MD
Global Medical Strategy Head of Data Science
Pfizer

MATT MIGHT, PhD
Director, Hugh Kaul Personalized Medicine Institute
University of Alabama at Birmingham

VICTORIA PRATT, PhD
President
Association for Molecular Pathology

DAWN BARRY
Co-Founder and President
Luna DNA

ELI CASDIN
Chief Investment Officer
Casdin Capital

ELLEN MATLOFF, MS, CGC
President & CEO
My Gene Counsel

JULIE RAMAGE
National Accounts Director, Diagnostics
Pfizer

ALEX DE WINTER
Managing Director
GE Ventures

NICK NACLERIO, PhD
Founding Partner
Illumina Ventures

BRYCE OLSON
Global Marketing Director, Health and Life Sciences
Intel